| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Psyence Biomedical Ltd.
13G/A
PBM · 74449F308
|
2.6% |
6/10/2026
Event 2/25/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.